Virtually everyone consumes prescription pharmaceuticals at one time or another. In each instance, the consumer is faced with a series of procedural steps and information. The procedural steps include submitting the prescription, waiting for it, picking up the prescription, and signing applicable notices. In some cases, the prescription is modified to satisfy the demands of the patient's insurance company. A large volume of information about the patient, pharmacy, physician, and drug is provided on the prescription sticker on the bottle, juxtaposed with numerous warning or cautionary labels haphazardly placed on the bottle. Additional information is provided on one or more printed, folded sheets, which are included with the prescription bottle.
Faced with this relatively chaotic presentation of seemingly obscure facts and requests, consumers can easily misunderstand many aspects related to their prescription. This situation is compounded when a consumer takes several prescriptions and/or when several members of the household each have one or more prescriptions, causing the multiple instructions and warnings to become overwhelming.
In addition, conventional pharmacy bottles can be difficult to grasp when opening, particularly for patients with arthritis and/or limited joint mobility and strength. Reduced vision also is a problem since distinguishing between multiple similar bottles requires very close inspection of the already confusing combination of the warnings and prescription label.
Given the importance of accuracy in consuming prescription medicine, the current confusion and difficulty for patient's to read and understand pharmaceutical prescription information is not acceptable.
Embodiments of the invention are directed to pharmacy bottle systems. In one embodiment, a prescription pharmacy bottle comprises a container and a label. The container includes a generally planar front portion having a generally rectangular shape and a generally planar back portion spaced from the front portion. The back portion has a generally rectangular shape and generally faces away in an opposite direction from the front portion. The label is secured to the container bearing printed matter related to a medication and includes a front portion secured on the front portion of the container and a back portion secured on the back portion of the container.
Embodiments of the invention will be described with respect to the figures, in which like reference numerals denote like elements, and in which:
In the following detailed description, reference is made to the accompanying drawings, which form a part hereof, and in which is shown by way of illustration specific embodiments in which the invention may be practiced. In this regard, directional terminology, such as “top,” “bottom,” “front,” “back,” “leading,” “trailing,” etc., is used with reference to the orientation of the Figure(s) being described. Because components of embodiments of the present invention can be positioned in a number of different orientations, the directional terminology is used for purposes of illustration and is in no way limiting. It is to be understood that other embodiments may be utilized and structural or logical changes may be made without departing from the scope of the present invention. The following detailed description, therefore, is not to be taken in a limiting sense, and the scope of the present invention is defined by the appended claims.
Embodiments of the invention are directed to a pharmacy bottle system and label system that significantly enhances a consumer's experience in filling a prescription at a retail pharmacy. In one embodiment, a pharmacy bottle system comprises a container, label, color ring, and a cap. The bottle container is sized and shaped to hold a medication from a prescription, such as pills, syrup, or other forms of medication. The bottle container includes a pair of generally flat, relatively large surfaces on opposite sides of the container for bearing the label, thereby making the label substantially easier to read. The label is configured for placement as a single piece or separate pieces, depending upon the type or size of the bottle container, to cover both of the opposite faces of the bottle container. Each label differentiates between types of information by segregating the different types of information onto different areas of the container and/or onto different areas of the label. In one embodiment, warning information is placed on a second portion of the label that is applied to a back portion of the bottle container, while conventional prescription information, such as patient name, drug name, physician name etc. is placed on a first portion of the label that is applied to a front portion of the bottle container. In one aspect, this arrangement of the location of the different types of information becomes fixed from prescription to prescription, so that a particular type of prescription-related information (e.g., drug name, warnings, patient name) is found at a fixed, dedicated location on the label and/or portion of bottle container each time a consumer fills a prescription.
In another embodiment, information on a portion of the label (e.g., a front portion or back portion) is further differentiated into primary information such as patient name, drug name and dose, and usage instructions and secondary information such as physician name/address, pharmacy name/address, etc. The primary information is presented in larger and/or bolder fonts, spaced away from secondary information, so that primary information conspicuously stands out to the consumer. In another embodiment, primary information is placed at an upper portion of the label and bottle container since it is the information most often required and used, with secondary information placed at a lower portion of label and bottle container to reflect its less frequent use.
In one embodiment, a bottle container is configured with a reverse orientation so that when a prescription label is applied to the container, the bottle appears right side up when its cap is in contact with a support surface (e.g., counter or table) and the container extends vertically upward from the cap in a manner that would initially appear to be upside down. The label on the bottle is configured with its text oriented to be read on the label with the bottle in this reverse orientation (e.g., cap down, container up). In one aspect, at least one face of the bottle container (that displays the label) is tilted slightly at an angle (relative to a vertical plane), so that the label can be read more easily when the bottle is supported on its cap, or held by a patient, in the reverse orientation (e.g., cap down, container up).
In one embodiment, a resilient, flexible colored ring is removably mounted around a mouth of the bottle container with different color rings being used by a pharmacy to aid consumers in distinguishing among prescriptions for different family members or among multiple types of medications for an individual. Each family member, or each type of medication, is assigned a different color.
In one embodiment, a bottle container and label are configured to form a slot on a back portion (or front portion) of the pharmacy bottle for removably receiving a patient information card within the slot. In another embodiment, a magnifying tool is substituted for the information card. In one aspect, the slot is oriented to enable slidable insertion and removal of the patient information card, and sized and shaped to enable a small portion of the card to protrude out of the slot (when fully inserted within the slot) to unobtrusively draw attention to the presence of the patient information card.
A label applied to the bottle container, the patient card, as well as other labels and printed information associated with filling prescriptions is provided by a label system. The label system comprises a complete integrated set of labels, sheets, and cards that is generated for each prescription by the pharmacist to expedite processing the prescription. In one embodiment, the label system is generated and customizable by a control monitor, via a user interface, operable by the pharmacist or retail administration. The label system also includes information such a patient monograph or other items that is generated along with the other labels, sheets, and cards when filling a prescription, so that the label system provides a single tool for producing all printed information used to process a prescription.
In another embodiment, different types of bottles enable different ways to enhance readability of printed information and patient handling of the bottles. Each of the different types of bottles in embodiments of the invention are used with the same label system, which is already adapted for application to the different types of bottles without requiring specific customization of the label each time a different type of bottle is used.
These embodiments and other embodiments of the invention are described and illustrated in greater detail in association with
As shown in
As shown in
In addition, back portion 66 of label 60 and back portion 28 of container 20 form a slot 69 which is adapted to removably receive information card 68, such as a patient information card which provides more extensive information, such as side effects, detailed manner of use, contraindications, pill description, etc. Information card 68 is sized and shaped to be removably insertable into slot 69, either as a single sheet or folded sheet. In one embodiment, slot 69 is oriented laterally so that information card 68 is slidable laterally relative to rear portion 66 of container 20, in a direction generally transverse to a longitudinal axis of container 20 (shown as line A in
Container 20 presents a unique combination of different shapes, surfaces, and features in one bottle 12. First, bottle 12 stands upright on a support surface 11, such as a table or counter, by placing cap 14 down onto the support surface 11 to cause container 20 to extend upwardly from support surface 11. In this orientation, spine portion 26 is considered a top of bottle 12 while cap 14 (which covers a mouth of bottle 12) is considered a bottom of bottle 12. From the standpoint of a conventional pharmacy bottle, this feature causes pharmacy bottle 12 to appear upside-down in orientation. However, this seemingly upside-down orientation of bottle 12 is actually a right-side-up orientation and maximizes readability of label 60 on container 20 and presents unique ways of handling a pharmacy bottle 12, as further described below. Moreover, this right-side-up orientation can be achieved by manually holding bottle 12 with spine portion 26 in a relatively higher position relative to cap 14 so that label 60 on bottle 12 can be read in an orientation from the spine portion 26 toward cap 14.
Second, in one embodiment, front portion 22 and back portion 28 of container 20 define a substantially planar surface that is rectangularly shaped, thereby defining a generally flat, broad surface especially suited for reading information on label 60. For example, this surface enables display of information in a manner in which all of the printed information on that surface can be read without turning or rotating bottle 12. In one embodiment, front portion 22 and back portion 28 of container 20 each extend at a slight angle relative to a vertical plane (shown as vertical plane V in
Third, as shown in
Fourth, as shown in
Spine portion 26 of container 20 comprises a slightly curved surface, providing a junction between front portion 22, back portion 28 and side portions 24. Side portions 24, front portion 22, and back portion 28 also join each other adjacent mouth 40.
Bottle 12 comprises multiple distinct profiles, depending upon the view taken of bottle 12, with each profile uniquely enhancing a patient's experience with bottle 12. In a first view, in which a consumer directly faces front portion 22 or back portion 28 of container 20, bottle 12 has a wide profile and generally flat, rectangular appearance. In a second view, in which a consumer directly faces either one of side portions 24 of container 20, bottle 12 has a narrow profile and a generally flat, trapezoidal appearance (or generally cone-shaped appearance). Bottle 12 also includes at least one more distinct profile that is seen when directly facing spine portion 26, which reveals a relatively narrow profile.
Accordingly, the combination of these three distinct profiles presents a radically different pharmacy bottle, with the distinct profiles contributing to the enhanced presentation of prescription-related information to the patient, as well as handling, storage, and retrieval of the bottle, as further described throughout this application.
In one embodiment, front portion 22 and back portion 28 are generally symmetric with each other regarding a size and general shape (e.g., generally rectangular) and side portions 24 are generally symmetric with each other regarding a size and general shape (e.g., generally trapezoidal). In another embodiment, front portion 22 and back portion 28 are generally asymmetric with each other regarding a size or a general shape and side portions 24 are generally asymmetric with each other regarding a size or a general shape.
In one embodiment, bottle 12 comprises ring 50. Ring 50 encircles a portion of threaded neck 42 and includes a color component for uniquely distinguishing between different bottles 12. In one embodiment, one color ring 50 represents a first type of medication while a second color ring represents a second type of medication. In another embodiment, one color ring 50 represents a first member of a patient's family while a second, different colored ring 50 represents a second member of the same patient's family. Additional uniquely colored rings can represent additional types of medication or additional family members, respectively. In another embodiment, different colored rings represent other parameters useful for uniquely identifying each single bottle among a plurality of bottles 12. In another embodiment, ring 50 is not mounted to bottle 12 for using color differentiation via ring 50. In another embodiment, ring 50 is removably mounted to bottle 12 but comprises a neutral color that does not differentiate between different bottles, such as the color of container 20. Accordingly, ring 50 further contributes to easy-to-follow presentation of information to the patient and others.
In addition to the benefits of the placement and orientation of label 60 on the various surfaces of container 20, label 60 includes additional features. In one embodiment, label 60 includes front portion 64, spine portion 65, and back portion 66. Front portion 64 of label 60 comprises, among other things, a patient identifier and a drug identifier while back portion 66 comprises warnings. Spine portion 65 comprises a patient identifier or drug identifier, as shown in
The segregation of the different types of information onto different portions of label 60, and therefore onto different portions of bottle 12, contribute to patient readability of pharmacy bottle 12. In one embodiment, front portion 64, spine portion 65, and back portion 66 of label 60 directly correspond to front portion 22, spine portion 26, and back portion 28 of container 20, respectively, to cause viewing of each type of information on bottle 12 on a separate face of bottle 12. In addition, front portion 64, spine portion 65, and back portion 66 of label 60 present three different readable faces of bottle 12 that are generally perpendicular to each other. Two of the faces, front portion 64 and back portion 66 of label 60, when applied to container 20, face in opposite directions relative to bottle 12, and hence are at a generally 180 degree angle relative to each other. Accordingly, in one embodiment, container 20 presents a three-faced container 20, with each face being generally perpendicular to each other so that in coordination with the three distinct portions of label 60 (e.g., front portion 64, spine portion 65, and back portions 66), bottle 12 provides three distinct, highly segregated reading surfaces for patient. This feature enhances separation of prescription related information onto different areas of bottle 12. Moreover, once a pharmacist or retailer designates one of the faces (e.g., a back face) of container 20 for a particular type of information (e.g. warning), the patient can rely on the same type of information being presented at that location of bottle 12 whenever a prescription is filled from that pharmacist or retailer. This feature reduces patient confusion, since a patient no longer has to search over the face of a conventional pharmacy bottle to determine where each piece of information is located in order to be able to coherently read the information on the pharmacy bottle.
In addition, in another embodiment, label 60 includes additional features for segregating information to ease patient readability of bottle 12. For example, as seen in
In one embodiment, spine portion 65 of label 60 is blank, as shown in
Back portion 66 of label 60 comprises warnings extending horizontally across back portion 66 in a stacked, generally parallel arrangement. As shown in
Additional aspects of label 60 will be described in more detail, particularly in association with
Accordingly, the full combination and interaction of the container, ring, label, and cap present an entirely different experience for a patient to use a pharmacy bottle, according to the embodiments of the invention.
In one embodiment, as shown in
In another embodiment, the first angle (α1) between front portion 22 relative to a generally vertical plane (V) and the second angle (α2) between back portion 28 relative to a generally vertical plane (V) are different from each other, thereby enabling one of the back portion 28 or the front portion 22 to extend at less of an angle relative to a generally vertical plane (V) and the respective other front portion 22 or back portion 28 to extend at a more of angle relative to that generally vertical plane (V). This feature enables favoring readability of one of the front portion 22 or back portion 28 (with a greater tilt angle) relative to the respective front portion or back portion 28 (with a lesser tilt angle).
Accordingly, as shown in
As shown in
As also shown in
As shown in
As shown in
As shown in
In one embodiment, back portion 28 of container 20 also comprises lip 85, which forms a protrusion on bottom portion 104 of back portion 28. Lip 85 enables precise placement of label 60 so that label 60 is properly aligned on back portion 28, particularly to enable placement of a non-stick portion of label 60 over recess 90, as will be further described in association with
Inner edge 94 of recess 90 prevents further sliding movement of an information card 68 laterally inward through slot 69, thereby helping to removably secure information card 68 in slot 69. This arrangement also causes the outer side of card 68 to protrude slightly outward from slot 69 (when card 68 is properly sized).
As shown in
The positioning of different types of information and types of text and font on label 60 can be modified and/or selected via control monitor 400, as further described in association with
As shown in
Spine portion 65 of label 60 comprises drug identifier 130 and/or patient identifier. In one embodiment, identifier 130 is in bold, large font letters to enhance quick identification of one bottle 12 relative to other bottles 12.
In one embodiment, front portion 64 has a height (H4) generally equal to a height (H6). Spine portion 65 has a height (H5). In one embodiment, height H4 and height H6 are substantially equal to each other and height (H5) is substantially less than height H4 or H6. Label 60 has a width (W3) that is generally equal to a width of front portion 22 and/or back portion 28 of container 20.
Non-stick portion 180 extends vertically across a majority of the height of back portion 66 (having a height H7) to create sufficient vertical space for slot 69 (
In one embodiment, label 60 is sized and shaped for larger pharmacy bottles, such as 30 dram and 60 dram bottles, while label 170 is sized and shaped for smaller pharmacy bottles, such as 15 dram. Accordingly, label 170 comprises substantially the same attributes and features of label 60, except being proportionally smaller to accommodate a smaller bottle size.
In one embodiment, label 60 includes a separation line 198 (also later identified as line 285 in
Paper sheet 204 comprises receipt 246, patient information card 250, and drug monograph 260 (or other detailed synopsis) divided by separable seams 262 to enable separation of receipt 246, patient information card 250, and drug monograph 260 from each other. In one embodiment, patient information card 250 corresponds to patient information card 68 (e.g.,
Label sheet 202 comprises first bottle label 220, second bottle label 222, bag tag 224, refill label 226, unit-of-use label 228, acknowledgement label 240, HIPPA label 242, and prescription tag 244.
In one embodiment, first bottle label 220 and second bottle label 222 have substantially the same features and attributes as label 60 and label 170 as described in association with
As shown in
Second bottle label 222 is sized and shaped for smaller-sized bottles, such as a 15 dram bottle. Second bottle label 222 comprises front portion 290 spine portion 292, and back portion 294 including non-stick portion 296. These components are described in greater detail in association with
Bag tag label 224 includes retail-sorting information and is removable for adhesive placement on a retail bag for identifying the bag with a particular patient and prescription. Refill label 226 includes retail information relating to processing refill prescriptions. Unit-of-use label 228 is sized and shaped for application to smaller single dose packaging, such as liquid vials, eye droppers, etc., and includes basic prescription information (e.g., patient, drug name, and dose) and/or usage instructions, but is not limited to those types of information.
Acknowledgement label 240 comprises a mechanism for the patient to acknowledge receipt of the drug and/or confirmation of instructions on how to take the drug. HIPAA label 242 comprises a notice to the patient, which the patient countersigns, regarding confidentiality and sharing of patient information. Prescription tag 244 is a label used in-house by the pharmacist or technician for handling the prescription.
In use, a pharmacist or technician enters or recalls patient and prescription information into a control module (via a graphical user interface) and then directs printing of that information onto label system 200. The various labels and information sheets/cards are separated from each other and/or removed from label system 200 for placement on bottles, bags, etc, or used for internal retail purposes. Accordingly, label system 200 enables generating a comprehensive set of information to fill and deliver a prescription to a consumer in an efficient, highly readable and organized manner, thereby improving consumer use of the prescription and retail delivery.
As shown in
General module 402 comprises size parameter 410, shape parameter 412, location parameter 414, orientation parameter 416, non-stick parameter 418, plain parameter 420, separation parameter 422, border parameter 424, anchor parameter 426, and side parameter 428. General module 402 also comprises font module 440, which includes color parameter 442, size parameter 444, type parameter 446, symbol parameter 448, orientation parameter 450, and spacing/border parameter 452.
General module 402 controls general aspects of label system 200 as a whole or as individual portions of label system 200. In one embodiment, one or more of these parameters such as size, shape, orientation of labels, and other general parameters can be pre-programmed or selected for a particular state or region, so that a pharmacist or technician need not select those parameters each time that a prescription is filled.
Size parameter 410 and shape parameter 412 separately control the size and shape, respectively, of a label or other portion (e.g., sheet, card, anchor, non-stick portion, etc.) of a label system, such as label system 200. Location parameter 414 and orientation parameter 416 separately control the location and orientation, respectively, of a label or other portion (e.g., sheet, card, anchor, non-stick portion, etc.) of a label system, such as label system 200.
Non-stick portion 418 and plain parameter 420 separately control which portions of label system 200 will be non-stick portions (e.g., non-stick portion 296 in
Separation parameter 422 and border parameter 424 separately control creation of separation lines and borders, respectively, between adjacent labels or other adjacent portions (e.g., sheet, card, anchor, non-stick portion, etc.) of a label system, such as label system 200. Anchor parameter 426 controls the creation, location, and the nature of anchor points or seams (e.g., anchor mechanism 206 in
As shown in
As shown in
Upon activation of one or more parameters of paper module 404, various aspects of printed matter, including its content and appearance, are further customizable or controllable via data module 408 and/or general module 402.
Label module 406 of control monitor 400 comprises large parameter 460, small parameter 462, front parameter 464, back parameter 466, spine parameter 468, and bottle-type parameter 470. Label module 406 also comprises acknowledgement parameter 472, unit-of-use parameter 474, notice parameter 476, prescription info parameter 478, refill parameter 480, bag-tag parameter 482, and other parameter 484.
Large parameter 460, small parameter 462, separately control pre-programmed parameters for large label sets and for small label sets, such as large bottle label 220 and small bottle label 222 of label system 200 (
Data module 408 of control monitor 400 controls which data, and where and how that data is expressed as printed matter on a label system for a bottle. Data module 408 enables control over entry, storage, retrieval, and display of this data for use in manipulating parameters of various modules, including data module 408, of control monitor 400. As shown in
Patient parameter 490 of data module 408 controls patient data such as name, address, phone, identification number(s), etc. while drug parameter 491 controls drug data such as drug name, drug supplier, etc. Usage parameter 492 controls data relating to proper usage of a drug while dose parameter 492 controls data relating to the prescribed dose of a drug. Warning parameter 494 controls data relating to cautions and warnings associated with a drug or other interacting substance/liquid. Additional parameter 495 enables an operator of control monitor 400 to add additional relevant data to a label or label system, on a case-by-case basis.
As shown in
Accordingly, control monitor 400 enables generating a label system, including an entire family of labels, sheets, and other types of printed matter for placement on and use with pharmacy bottles, as described and illustrated throughout this application.
As shown in
Front portion 502 receives a front portion 520 of a label 515, while back portion 506 of bottle 500 receives a back portion 522 and spine portion 524 of label 515. Front portion 520, spine portion 524, and back portion 522 of label 515 comprises generally the same features and attributes of label 60, 170 as previously described and illustrated in association with
Label 640 on bottle 600 forms a slot 650 for removably receiving a patient information card 652, in a manner substantially the same as for the embodiments of
As shown in
In other embodiments, protrusion 620 is not strictly limited to the elongated ring 620, but can include other shapes and configurations, such as a rectangular shaped protrusion, a circular shaped protrusion, an elliptical-shaped protrusion, a triangular-shaped protrusion, etc. Finally, in another embodiment, bottle 12 does not include protrusion 620 on side portions 606 and 608.
As shown in
Moreover, in other embodiments, a recess that extends laterally across the entire width of rear portion of a bottle (such as rear portion 604 of bottle 600) can be substituted for the recess in the embodiments of
In another embodiment, the recess 660 that extends laterally across the entire width of rear portion 604 of bottle 600 can be replaced with a recess, such as recess 90 (
In another embodiment, side portions 606 and 608 are dissimilar to each other. As shown in
In one embodiment, each side portion 706, 708 comprises a protrusion 720, including ring 721 and surface 722, and surface 718, having substantially the same features and attributes as side portions 620 of bottle 600 of the embodiment of
Embodiments of the invention significantly enhance a patient's experience in becoming informed about a prescription directly from the prescription bottle and significantly enhance a retail pharmacy's ability to consistently fill and deliver the prescription in a manner that maintains the patient's satisfactory experiences with a pharmacy purchase.
Although specific embodiments have been illustrated and described herein, it will be appreciated by those of ordinary skill in the art that a variety of alternate and/or equivalent implementations may be substituted for the specific embodiments shown and described without departing from the scope of the present invention. This application is intended to cover any adaptations or variations of the specific embodiments discussed herein. Therefore, it is intended that this invention be limited only by the claims and the equivalents thereof.
Number | Name | Date | Kind |
---|---|---|---|
D11149 | Hood | Apr 1879 | S |
D18997 | Underhill | Apr 1889 | S |
406017 | Woodward et al. | Jun 1889 | A |
605213 | Weller | Jun 1898 | A |
624701 | Stevenson | May 1899 | A |
716793 | Vogeler | Dec 1902 | A |
D45565 | Lloyd | Apr 1914 | S |
1181098 | Lambert | Apr 1916 | A |
1289218 | Maiden | Dec 1918 | A |
1554191 | Alexander | Sep 1925 | A |
1653608 | Allen | Dec 1927 | A |
1686354 | Wallace | Oct 1928 | A |
1769147 | Lennon | Jul 1930 | A |
1815268 | Newbery | Jul 1931 | A |
1850369 | Andrews | Mar 1932 | A |
1993978 | Plochman | Mar 1935 | A |
2007685 | Blake | Jul 1935 | A |
2110768 | Kellogg | Mar 1938 | A |
D128282 | Gelinas et al. | Jul 1941 | S |
2270277 | Dowd | Jan 1942 | A |
D132185 | McIntosh | Apr 1942 | S |
2328806 | Hoofer | Sep 1943 | A |
2528259 | Annunziata | Oct 1950 | A |
2659614 | Cook et al. | Nov 1953 | A |
2844893 | Keller | Jul 1958 | A |
2847971 | Painter | Aug 1958 | A |
2920777 | Cole | Jan 1960 | A |
2961108 | Johnson | Nov 1960 | A |
3256978 | Srigley et al. | Jun 1966 | A |
3331521 | Paige | Jul 1967 | A |
3423861 | Forsyth | Jan 1969 | A |
3433378 | Ross | Mar 1969 | A |
3437194 | Ames et al. | Apr 1969 | A |
3757994 | Skoetsch | Sep 1973 | A |
3787993 | Lyon | Jan 1974 | A |
3822780 | Ulmer et al. | Jul 1974 | A |
3826222 | Romick | Jul 1974 | A |
3850326 | Ryles | Nov 1974 | A |
3923180 | Fields | Dec 1975 | A |
3996879 | Walton | Dec 1976 | A |
4022352 | Pehr | May 1977 | A |
4044889 | Orentreich et al. | Aug 1977 | A |
4064645 | Wood | Dec 1977 | A |
RE29793 | Pehr | Oct 1978 | E |
4143786 | Goldberg et al. | Mar 1979 | A |
4150760 | d'Orgelys | Apr 1979 | A |
D255054 | Kingsford | May 1980 | S |
4246709 | Selleslags | Jan 1981 | A |
4263734 | Bradshaw | Apr 1981 | A |
4284200 | Bush et al. | Aug 1981 | A |
4334638 | Stock | Jun 1982 | A |
D270998 | Stark | Oct 1983 | S |
D274309 | Aldrich, III | Jun 1984 | S |
4535903 | Franchi | Aug 1985 | A |
D280601 | Biesecker | Sep 1985 | S |
D282909 | Biesecker | Mar 1986 | S |
D285535 | Buchholz et al. | Sep 1986 | S |
4732411 | Siegel | Mar 1988 | A |
4799712 | Biava et al. | Jan 1989 | A |
D300119 | Pacquin | Mar 1989 | S |
4813570 | Pontoppidan | Mar 1989 | A |
4863026 | Perkowski | Sep 1989 | A |
4868027 | Hunkeler et al. | Sep 1989 | A |
4881648 | Hagerty | Nov 1989 | A |
4883180 | Humphrey et al. | Nov 1989 | A |
D305505 | Kunesh | Jan 1990 | S |
4890742 | Allison | Jan 1990 | A |
4913083 | Valvo et al. | Apr 1990 | A |
4918604 | Baum | Apr 1990 | A |
4919285 | Roof et al. | Apr 1990 | A |
4941573 | Fuerstman | Jul 1990 | A |
4972657 | McKee | Nov 1990 | A |
4991877 | Lieberman | Feb 1991 | A |
5011032 | Rollman | Apr 1991 | A |
5020682 | Dutt | Jun 1991 | A |
D319181 | Balavich | Aug 1991 | S |
D323780 | Addante | Feb 1992 | S |
5102169 | Mayfield | Apr 1992 | A |
5145080 | Imbery, Jr. | Sep 1992 | A |
5165546 | Jaeger et al. | Nov 1992 | A |
5172936 | Sullivan et al. | Dec 1992 | A |
D333618 | Patel et al. | Mar 1993 | S |
5193032 | Hirth | Mar 1993 | A |
5204775 | McDevitt | Apr 1993 | A |
5261702 | Mayfield | Nov 1993 | A |
D342452 | Monaghan | Dec 1993 | S |
5284363 | Gartner et al. | Feb 1994 | A |
5301802 | Nemeroff | Apr 1994 | A |
5309279 | Halstead | May 1994 | A |
5342093 | Weernink | Aug 1994 | A |
D350691 | Simion | Sep 1994 | S |
5343647 | Bulka | Sep 1994 | A |
5346069 | Intini | Sep 1994 | A |
D351796 | Deddens | Oct 1994 | S |
5351991 | McDonald | Oct 1994 | A |
D355125 | Patel et al. | Feb 1995 | S |
D355126 | Paulovich et al. | Feb 1995 | S |
5403636 | Crum | Apr 1995 | A |
D360134 | Snyder | Jul 1995 | S |
5448844 | Miller, Jr. et al. | Sep 1995 | A |
5476420 | Manning | Dec 1995 | A |
D370636 | Crawford | Jun 1996 | S |
5588239 | Anderson | Dec 1996 | A |
5601314 | Burns et al. | Feb 1997 | A |
5642906 | Foote et al. | Jul 1997 | A |
5660138 | Hirsch | Aug 1997 | A |
5662239 | Heuvelman | Sep 1997 | A |
D389064 | Sethi et al. | Jan 1998 | S |
5704144 | Groth | Jan 1998 | A |
5704648 | Brown et al. | Jan 1998 | A |
5713681 | Venne et al. | Feb 1998 | A |
5718347 | Walker et al. | Feb 1998 | A |
5719828 | Haas et al. | Feb 1998 | A |
5729922 | Peterson et al. | Mar 1998 | A |
5730292 | Jones | Mar 1998 | A |
5758440 | Yudin | Jun 1998 | A |
5760975 | DiGiovanni | Jun 1998 | A |
D395828 | Lecoule | Jul 1998 | S |
5779072 | Krebs | Jul 1998 | A |
5788974 | D'Amico et al. | Aug 1998 | A |
5799815 | Lang | Sep 1998 | A |
5800144 | Glenn et al. | Sep 1998 | A |
5829789 | Treleaven et al. | Nov 1998 | A |
5887736 | Mar | Mar 1999 | A |
5918758 | Galton-Fenzi | Jul 1999 | A |
D413067 | Haley | Aug 1999 | S |
5980352 | Rigberg | Nov 1999 | A |
6003902 | Petkovsek | Dec 1999 | A |
D419077 | Sultan | Jan 2000 | S |
6023865 | Preuss | Feb 2000 | A |
6068300 | Vijuk et al. | May 2000 | A |
D427073 | Gaffney et al. | Jun 2000 | S |
6081392 | Pensmith | Jun 2000 | A |
6086702 | Rea | Jul 2000 | A |
6158779 | Petrick | Dec 2000 | A |
6196593 | Petrick et al. | Mar 2001 | B1 |
6209921 | Hogan et al. | Apr 2001 | B1 |
6220439 | Virvo | Apr 2001 | B1 |
6226564 | Stuart | May 2001 | B1 |
6241844 | Petkovsek | Jun 2001 | B1 |
D445338 | Helleu | Jul 2001 | S |
6270121 | Dolan et al. | Aug 2001 | B1 |
6278545 | Napier | Aug 2001 | B1 |
6360462 | Mengel | Mar 2002 | B1 |
D456271 | Maloney | Apr 2002 | S |
6366401 | Gonda et al. | Apr 2002 | B1 |
6367639 | Mar | Apr 2002 | B1 |
6367640 | Julian | Apr 2002 | B1 |
6386367 | Bayliss, IV | May 2002 | B1 |
6402872 | Key | Jun 2002 | B1 |
6491164 | Virvo | Dec 2002 | B1 |
D470415 | Weber | Feb 2003 | S |
6549345 | Cardarelli | Apr 2003 | B1 |
6568530 | Takahashi et al. | May 2003 | B2 |
6594928 | Clawson et al. | Jul 2003 | B1 |
D480002 | Canepa | Sep 2003 | S |
D480005 | Conway | Sep 2003 | S |
6621629 | Blumenthal et al. | Sep 2003 | B2 |
D480960 | Gray et al. | Oct 2003 | S |
6669804 | Pendry et al. | Dec 2003 | B2 |
6681945 | Harrold | Jan 2004 | B1 |
6712398 | Fox et al. | Mar 2004 | B1 |
6722495 | Fresnel | Apr 2004 | B2 |
6745505 | Moran | Jun 2004 | B2 |
D497311 | Walsh et al. | Oct 2004 | S |
6860390 | Bowman | Mar 2005 | B2 |
6860513 | Kaufman | Mar 2005 | B2 |
6964345 | Wetherell, Jr. et al. | Nov 2005 | B2 |
D520365 | Andoh | May 2006 | S |
D526569 | Wurster et al. | Aug 2006 | S |
D539651 | Snyder | Apr 2007 | S |
D541159 | Robinson | Apr 2007 | S |
7225937 | Schroeder | Jun 2007 | B2 |
7311205 | Adler et al. | Dec 2007 | B2 |
20010017817 | De La Huerga | Aug 2001 | A1 |
20010054817 | Kelley et al. | Dec 2001 | A1 |
20020020088 | Kreutner | Feb 2002 | A1 |
20020041091 | Eippert | Apr 2002 | A1 |
20020063739 | Gosden et al. | May 2002 | A1 |
20020088732 | Takahashi et al. | Jul 2002 | A1 |
20020129758 | Hanley et al. | Sep 2002 | A1 |
20020162261 | West et al. | Nov 2002 | A1 |
20020171238 | Kozlowski et al. | Nov 2002 | A1 |
20030025320 | Shoemaker | Feb 2003 | A1 |
20030028392 | Davies | Feb 2003 | A1 |
20030091687 | Copelan | May 2003 | A1 |
20030127351 | Takahashi et al. | Jul 2003 | A1 |
20030192211 | Elias | Oct 2003 | A1 |
20030193181 | Hung | Oct 2003 | A1 |
20030193185 | Valley et al. | Oct 2003 | A1 |
20030205897 | Kaufman | Nov 2003 | A1 |
20030214129 | Adler | Nov 2003 | A1 |
20040045863 | Rhoades | Mar 2004 | A1 |
20040050750 | Hannan et al. | Mar 2004 | A1 |
20040056479 | Fox et al. | Mar 2004 | A1 |
20040075272 | Kaufman | Apr 2004 | A1 |
20040193454 | Foote et al. | Sep 2004 | A1 |
20040232023 | Bansal et al. | Nov 2004 | A1 |
20070102316 | Van Der Krogt et al. | May 2007 | A1 |
Number | Date | Country |
---|---|---|
3723671 | Aug 1988 | DE |
0 316 636 | May 1989 | EP |
0146095 | Aug 1989 | EP |
0609955 | Apr 1998 | EP |
0609954 | Jul 1998 | EP |
0924676 | Jun 1999 | EP |
2 006 713 | May 1979 | GB |
10297640 | Nov 1998 | JP |
WO03098275 | Nov 2003 | WO |
2004048216 | Jun 2004 | WO |
Number | Date | Country | |
---|---|---|---|
20060163103 A1 | Jul 2006 | US |